Mather Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Mather Group's MEDP Position: Q3 2026 in Review
Mather Group increased its Medpace (MEDP) stake by 50% in Q3 2026, buying an estimated $8.79K and bringing the position to 45 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.
Mather Group first reported a position in MEDP in Q1 2024 and has held it in 9 quarters since. 135 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Mather Group held 45 shares of Medpace worth $28.1K as of Q3 2026.
- Mather Group bought 15 Medpace shares in Q3 2026, an estimated $8.79K.
- Medpace made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1343 holding.
- Mather Group first reported a position in Medpace in Q1 2024 and has held it in 9 quarters since.
- 135 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.